Documents

A list of downloadable documents created during development.

Review proposal consultation

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): Equality Impact Assessment - guidance development

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): appraisal consultation 2

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with glucocorticoids): appraisal consultation

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with corticosteroids: equality impact assessment - scoping

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with corticosteroids: response to consultee and commentator comments on the draft scope and provisional matrix

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with corticosteroids: final matrix

Vasculitis (anti-neutrophil cytoplasmic antibody-associated) - rituximab (with corticosteroids): final scope